Phenylalanine derivatives as endothelin antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514538, 514539, 514562, 514563, 514567, 514 63, 514617, 514464, 560 40, 562439, 562446, 549435, 549444, 556419, C07C22936, C07C22930, C07C31760

Patent

active

056589433

ABSTRACT:
Novel antagonists of endothelin are described, as well as novel intermediates used in their preparation, methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, essential, renovascular, malignant and pulmonary hypertension, cerebral infarction, myocardial ischemia, cerebral ischemia, congestire heart failure and subarachnoid hemorrhage.

REFERENCES:
patent: 3714241 (1973-01-01), Grenda
patent: 3930017 (1975-12-01), Kummer et al.
patent: 4497964 (1985-02-01), Ojima et al.
patent: 5198548 (1993-03-01), Beylin et al.
patent: 5246943 (1993-09-01), Blankley et al.
Davies et al., CA 118:81342 (1993), registry No. 90656-96-5.
Nie et al., CA 116:255995 (1992), registry No. 141523-18-4.
Lavin et al., CA 114:75177 (1991), registry No. 131930-02-4.
Hansen et al., CA 102:149743 (1985), registry No. 94732-12-4.
Somack et al., CA 96:28824 (1982), registry Nos. 80248-16-4, 80248-17-5, 80248-20-0 and 80248-21-1.
Gosteli, CA 77:114271 (1972), registry No. 36943-43-8.
Kirby et al., CA 76:59149 (1972), registry No. 35175-72-5.
Mukherjee et al., CA 75:5371 (1971), registry No. 32299-75-5.
Matsuura et al., CA 72:44093 (1970), registry No. 24956-73-8.
Matsuura et al., CA 69:52461 (1968), registry No. 19103-40-3.
Block, CA 67:108980 (1967), registry Nos. 15962-67-1 and 15962-69-3.
S. Klutchko, et al., Bioorganic & Medicinal Chemistry Letters, 1994, 4:1, 57-62.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phenylalanine derivatives as endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenylalanine derivatives as endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalanine derivatives as endothelin antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1105223

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.